![](/img/cover-not-exists.png)
P706 Lower need for adalimumab dose intensification in IBD patients treated with combined immune suppression compared with adalimumab monotherapy
Kovacs, J, Kadleckova, B, Gombosova, L, Novotna, L, Barlova, E, Lucenincova, J, Mikus, P, Zakuciova, M, Zelinkova, ZVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.833
Date:
January, 2018
File:
PDF, 54 KB
english, 2018